Replies to post #108024 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

MMSE improvement from 21-23 over two months. Not inconsistent with short term effects of Donepezil.

You omitted the adverse effects at a higher dosage.

Book is copyright 1998 - Donepezil is now proven to provide nothing more that halt of decline... Maybe that lady had a "placebo effect".

[blu_1]

But that's obfuscating the fact that she was only on the donepezil for 2 months, and she was only on 10mg of donepezil for 1 month. Whereas the Australian woman had been on 2-73 for 8-9 months when her interview was filmed. You conveniently failed to mention that nugget of info. And the Australian woman might not have even been on what will be determined to be the optimized dose of 2-73. Everybody knows donepezil's improvement is short lived, just a few months. That's why abbreviated 3 month trials for Alzheimers are deceiving. Seeing improvement or stabilization more than 6 months or one year out, now that is impressive.

Have you invested in AVXL?